# N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE

> **NCT04920448** · PHASE2 · TERMINATED · sponsor: **University Hospital, Caen** · enrollment: 12 (actual)

## Conditions studied

- Stroke, Ischemic

## Interventions

- **DRUG:** N-Acetyl cysteine

## Key facts

- **NCT ID:** NCT04920448
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-16
- **Primary completion:** 2023-04-25
- **Final completion:** 2024-04-25
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** lack of patients
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04920448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04920448, "N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04920448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*